Sunshine Biopharma, Inc. (SBFM)

USD 2.75

(0.37%)

Total Debt Summary of Sunshine Biopharma, Inc.

  • Sunshine Biopharma, Inc.'s latest annual total debt in 2023 was 657.7 Thousand USD , down -84.61% from previous year.
  • Sunshine Biopharma, Inc.'s latest quarterly total debt in 2024 Q2 was 577.35 Thousand USD , down -5.72% from previous quarter.
  • Sunshine Biopharma, Inc. reported annual total debt of 4.27 Million USD in 2022, up 124.96% from previous year.
  • Sunshine Biopharma, Inc. reported annual total debt of 1.9 Million USD in 2021, down -0.69% from previous year.
  • Sunshine Biopharma, Inc. reported quarterly total debt of 577.35 Thousand USD for 2024 Q2, down -5.72% from previous quarter.
  • Sunshine Biopharma, Inc. reported quarterly total debt of 734.43 Thousand USD for 2023 Q1, down -82.82% from previous quarter.

Annual Total Debt Chart of Sunshine Biopharma, Inc. (2023 - 2007)

Historical Annual Total Debt of Sunshine Biopharma, Inc. (2023 - 2007)

Year Total Debt Total Debt Growth
2023 657.7 Thousand USD -84.61%
2022 4.27 Million USD 124.96%
2021 1.9 Million USD -0.69%
2020 1.91 Million USD 167.36%
2019 715.56 Thousand USD -24.88%
2018 952.6 Thousand USD 18.73%
2017 802.31 Thousand USD 238.57%
2016 236.97 Thousand USD -79.22%
2015 1.14 Million USD 137.56%
2014 480.12 Thousand USD 3740.99%
2013 12.5 Thousand USD -80.0%
2012 62.5 Thousand USD 0.0%
2011 - USD 0.0%
2010 - USD -100.0%
2009 31 Thousand USD 82.35%
2008 17 Thousand USD 0.0%
2007 - USD 0.0%

Peer Total Debt Comparison of Sunshine Biopharma, Inc.

Name Total Debt Total Debt Difference
Theratechnologies Inc. 58.96 Million USD 98.885%
Harrow Health, Inc. 190.5 Million USD 99.655%
Dynavax Technologies Corporation 256.91 Million USD 99.744%
Biofrontera Inc. 5.39 Million USD 87.818%
Cronos Group Inc. 2.53 Million USD 74.105%
Sonoma Pharmaceuticals, Inc. 608 Thousand USD -8.175%
Ironwood Pharmaceuticals, Inc. 715.53 Million USD 99.908%
Kala Pharmaceuticals, Inc. 36.32 Million USD 98.189%
RedHill Biopharma Ltd. 1.17 Million USD 43.93%
Cumberland Pharmaceuticals Inc. 18.42 Million USD 96.431%
Radius Health, Inc. 365.31 Million USD 99.82%
Universe Pharmaceuticals INC 5.48 Million USD 88.003%
DURECT Corporation 20.74 Million USD 96.83%
ProPhase Labs, Inc. 21.38 Million USD 96.924%
Safety Shot Inc 1.54 Million USD 57.539%
Phibro Animal Health Corporation 525.45 Million USD 99.875%
China SXT Pharmaceuticals, Inc. 2.64 Million USD 75.157%
Alvotech 1.07 Billion USD 99.939%
Assertio Holdings, Inc. 40.91 Million USD 98.392%
Supernus Pharmaceuticals, Inc. 41.52 Million USD 98.416%
Rockwell Medical, Inc. 13.43 Million USD 95.106%
Procaps Group S.A. 285.93 Million USD 99.77%
Intra-Cellular Therapies, Inc. 16.93 Million USD 96.117%
SCYNEXIS, Inc. 15.08 Million USD 95.639%
Aytu BioPharma, Inc. 15.12 Million USD 95.653%
Viatris Inc. 18.12 Billion USD 99.996%
OptiNose, Inc. 131.74 Million USD 99.501%
SIGA Technologies, Inc. 1.46 Million USD 55.075%
Tilray Brands, Inc. 387.31 Million USD 99.83%
PetIQ, Inc. 468.3 Million USD 99.86%
Sunshine Biopharma, Inc. 657.7 Thousand USD 0.0%
Neurocrine Biosciences, Inc. 428.4 Million USD 99.846%
Guardion Health Sciences, Inc. - USD -Infinity%
Alimera Sciences, Inc. 67.39 Million USD 99.024%
Collegium Pharmaceutical, Inc. 674.28 Million USD 99.902%
Silver Spike Investment Corp. - USD -Infinity%
Shuttle Pharmaceuticals Holdings, Inc. 1.08 Million USD 39.532%
Organogenesis Holdings Inc. 119.35 Million USD 99.449%
Journey Medical Corporation 17.73 Million USD 96.29%
Petros Pharmaceuticals, Inc. 8.27 Million USD 92.053%
Alpha Teknova, Inc. 30.45 Million USD 97.841%
Clever Leaves Holdings Inc. 2.08 Million USD 68.486%
Lifecore Biomedical, Inc. 130.36 Million USD 99.495%
PainReform Ltd. 86 Thousand USD -664.773%
Cosmos Health Inc. 12.42 Million USD 94.706%
Avadel Pharmaceuticals plc 35.38 Million USD 98.141%
TherapeuticsMD, Inc. 8 Million USD 91.784%
Embecta Corp. 1.63 Billion USD 99.96%
Regencell Bioscience Holdings Limited 59.8 Thousand USD -999.712%
Talphera, Inc. - USD -Infinity%
Pacira BioSciences, Inc. 586.04 Million USD 99.888%
Incannex Healthcare Limited 373 Thousand USD -76.328%
Cyclo Therapeutics, Inc. 1.03 Million USD 36.338%
Shineco, Inc. 29.65 Million USD 97.782%
Procaps Group, S.A. 285.93 Million USD 99.77%
ANI Pharmaceuticals, Inc. 315.32 Million USD 99.791%
Aquestive Therapeutics, Inc. 98.82 Million USD 99.334%
Lantheus Holdings, Inc. 616.94 Million USD 99.893%
Alvotech 1.07 Billion USD 99.939%
Hempacco Co., Inc. 13.72 Million USD 95.208%
Eagle Pharmaceuticals, Inc. 62.46 Million USD 98.947%
Bright Green Corporation 1.85 Million USD 64.483%
Esperion Therapeutics, Inc. 540.94 Million USD 99.878%
Kamada Ltd. 8.74 Million USD 92.483%
Indivior PLC 281.6 Million USD 99.766%
Evoke Pharma, Inc. 5 Million USD 86.846%
Flora Growth Corp. 3.67 Million USD 82.089%
Cyclo Therapeutics, Inc. 1.03 Million USD 36.338%
Evolus, Inc. 126.54 Million USD 99.48%
HUTCHMED (China) Limited 86.13 Million USD 99.236%
Amphastar Pharmaceuticals, Inc. 623.64 Million USD 99.895%
Akanda Corp. 3.99 Million USD 83.552%